STATE STREET CORP - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 35 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$51,182
-24.1%
81,2410.0%0.00%
Q2 2023$67,430
+88.6%
81,2410.0%0.00%
Q1 2023$35,746
-62.7%
81,241
-50.0%
0.00%
Q4 2022$95,848
+68.2%
162,482
+100.0%
0.00%
Q3 2022$57,000
-51.7%
81,2410.0%0.00%
Q2 2022$118,000
-25.8%
81,241
+91.9%
0.00%
Q1 2022$159,000
+65.6%
42,341
+244.2%
0.00%
Q4 2021$96,00012,3000.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
First PREMIER Bank 652,440$946,0000.28%
METEORA CAPITAL, LLC 292,538$424,0000.08%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 78,115$113,0000.02%
SILVER OAK SECURITIES, Inc 51,941$64,0000.01%
Shaolin Capital Management LLC 275,000$399,0000.01%
Elgethun Capital Management 13,296$18,0000.01%
LGL PARTNERS, LLC 23,000$33,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,000$122,0000.00%
Spectrum Management Group, LLC 5,030$7,0000.00%
Veritable, L.P. 43,551$63,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders